相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8)
Ana Gutierrez-Fernandez et al.
FASEB JOURNAL (2007)
Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis
Caroline T. Y. Cheung et al.
LABORATORY INVESTIGATION (2007)
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure
Andrew T. Yan et al.
JOURNAL OF CARDIAC FAILURE (2006)
Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis
Stephane Heymans et al.
CIRCULATION (2006)
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis
Ann-Marie Calander et al.
MICROBES AND INFECTION (2006)
Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis
Rosemarijn Renckens et al.
JOURNAL OF IMMUNOLOGY (2006)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis
C Cheung et al.
CARDIOVASCULAR PATHOLOGY (2006)
Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects
M Saglam et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis -: Association with reduced myocardial interleukin-1β and MMP-8 expression and a modulated immune response
M Pauschinger et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice
S Heymans et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures -: The Framingham Heart Study
J Sundström et al.
CIRCULATION (2004)
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
M Balbín et al.
NATURE GENETICS (2003)
Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities
PE Van den Steen et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Gelatinase B/matrix metalloproteinase-9 cleaves interferon-β and is a target for immunotherapy
I Nelissen et al.
BRAIN (2003)
Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice
B Yanagawa et al.
LABORATORY INVESTIGATION (2003)
Decreased expression of membrane IL-5 receptor α on human eosinophils:: II.: IL-5 down-modulates its receptor via a proteinase-mediated process
LY Liu et al.
JOURNAL OF IMMUNOLOGY (2002)
Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction
J Li et al.
CARDIOVASCULAR RESEARCH (2002)
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
A Ducharme et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)